Banke Biotech

班科生物

Banke Biotech

Biotech/Healthcare

Banke Bio is long committed to developing innovative antibody drugs and has built a comprehensive multi-dimensional antibody drug R&D platform. It has formed and is refining a nanobody drug translation and operations team.

Latest round: Angel (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-08-01